证券代码：600666 证券简称：奥瑞德 公告编号：临 2025-048 股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 股东名称 | 共青城坤舜创业投资合伙企业（有限合伙） | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是 | √否 | | | 直接持股 5%以上股东 | □是 | √否 | 一、减持主体减持前基本情况 奥瑞德光电股份有限公司 1 股东持股的基本情况：本次减持计划实施前，共青城坤舜创业投资合 伙企业（有限合伙）（以下简称"共青城坤舜"）持有公司股份 136,970,000 股，占公司总股本的 4.96%。 减持计划的实施结果情况：公司于 2025 年 8 月 6 日在上海证券交易所 网站（https://www.sse.com.cn）披露了《股东减持股份计划公告》（公 告编号：临 2025-036）。共青城坤舜拟于 2025 年 8 月 27 日至 10 月 17 日期间，通过集中竞价交 ...

奥瑞德光电股份有限公司 2025 年第二次临时股东会会议资料 九、宣布会议结束。 奥瑞德光电股份有限公司 2025 年 10 月 股票代码：600666 奥瑞德 2025 年第二次临时股东会会议资料 奥瑞德光电股份有限公司 2025 年第二次临时股东会会议议程 时间：2025年10月28日下午14:30 地点：北京市海淀区知春路68号领航科技大厦11层西侧北京智算力数字科技有限公司 会议主持人：董事长朱三高先生 会议议程： 一、会议主持人宣布会议开始，并介绍会议议程及须知； 2025 年 10 月 28 日 2 二、审议会议议案； 三、股东代表发言或提问（如有）以及对有关询问进行回答（若有）； 四、对各项议案进行审议并表决； 五、宣读会议现场及网络投票表决结果； 六、宣读股东会决议； 七、律师宣读关于本次现场股东会的法律意见； 八、董事在股东会议决议上签名； 股票代码：600666 奥瑞德 2025 年第二次临时股东会会议资料 奥瑞德光电股份有限公司 2025年第二次临时股东会须知 为了维护全体股东的合法权益，确保股东会高效有序顺利进行，根据有关法律法 规和中国证监会《上市公司股东会规则》的要求，以及《公司章 ...

Group 1 - The core point of the article is that Aorede (600666.SH) announced the completion of a share reduction plan by Qiongcheng Kunshun, which involved a total reduction of 16.01 million shares, accounting for 0.58% of the company's shares [1] Group 2 - The share reduction plan was executed as per the notice received from Qiongcheng Kunshun, and the plan's duration has now expired [1]

Group 1 - The core point of the news is that Aorede's stock price increased by 5.11% to 3.50 CNY per share, with a trading volume of 2.19 billion CNY and a turnover rate of 2.68%, resulting in a total market capitalization of 9.672 billion CNY [1] - Aorede Optical Co., Ltd. is located in Harbin, Heilongjiang Province, and was established on November 25, 1992. It was listed on July 12, 1993. The company's main business includes the research, production, and sales of sapphire crystal materials, sapphire crystal growth equipment, and sapphire products [1] - The revenue composition of Aorede's main business includes computing power services at 52.31%, sapphire products at 39.39%, and others at 8.30% [1] Group 2 - According to data from the top ten heavy stocks of funds, one fund under People's Insurance Asset holds Aorede as a major position. The fund, People's Insurance Select Mixed A (005041), held 1.0855 million shares in the second quarter, accounting for 5.14% of the fund's net value, making it the largest heavy stock [2] - The People's Insurance Select Mixed A fund has a total scale of 73.4629 million CNY and has achieved a return of 19.82% this year, ranking 4403 out of 8160 in its category. Over the past year, it has returned 25.78%, ranking 3775 out of 8021, and since its inception, it has returned 53.06% [2]

Company Overview - Aorede Optical Co., Ltd. is located in Harbin, Heilongjiang Province, and was established on November 25, 1992, with its listing date on July 12, 1993 [2] - The company's main business includes the research, production, and sales of sapphire crystal materials, sapphire crystal growth equipment, and sapphire products, as well as precision processing equipment for hard and brittle materials and 3D glass bending machines [2] - The revenue composition of Aorede is as follows: computing services 52.31%, sapphire products 39.39%, and others 8.30% [2] Financial Performance - For the first half of 2025, Aorede achieved operating revenue of 219 million yuan, representing a year-on-year growth of 10.12% [2] - The net profit attributable to the parent company for the same period was 61.39 million yuan, showing a significant year-on-year increase of 1263.22% [2] - Cumulative cash distribution since Aorede's A-share listing amounts to 82.17 million yuan, with no cash distribution in the last three years [3] Stock Performance - As of October 17, Aorede's stock price increased by 2.10%, reaching 3.40 yuan per share, with a trading volume of 153 million yuan and a turnover rate of 1.89%, resulting in a total market capitalization of 9.396 billion yuan [1] - Year-to-date, Aorede's stock price has risen by 33.86%, with a slight increase of 0.89% over the last five trading days, a decrease of 7.10% over the last 20 days, and a 0.89% increase over the last 60 days [1] - Aorede has appeared on the "Dragon and Tiger List" six times this year, with the most recent appearance on August 11, where it recorded a net purchase of 52.24 million yuan [1] Shareholder Information - As of June 30, 2025, Aorede had 133,800 shareholders, an increase of 40.06% from the previous period, with an average of 18,089 circulating shares per person, a decrease of 28.60% [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the ninth largest shareholder, holding 11.40 million shares as a new shareholder [3]

证券代码：600666 证券简称：奥瑞德 公告编号：临 2025-047 奥瑞德光电股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次投资者说明会以网络互动形式召开，公司将针对 2025 年半年度的经营 成果及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范 围内就投资者普遍关注的问题进行回答。 二、说明会召开的时间、地点 （一） 会议召开时间：2025 年 10 月 21 日（星期二）09:00-10:00 会议召开时间：2025 年 10 月 21 日（星期二）09:00-10:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 （二） 会议召开地点：上证路演中心 （三） 会议召开方式：上证路演中心网络互动 三、参加人员 投资者可于 2025 年 10 月 15 日（星期三）至 10 ...

证券代码：600666 证券简称：奥瑞德 公告编号：临 2025-046 奥瑞德光电股份有限公司 关于召开2025年第二次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 2025年第二次临时股东会 召开的日期时间：2025 年 10 月 28 日 14 点 30 分 召开地点：北京市海淀区知春路 68 号领航科技大厦 11 层西侧北京智算力数 股东会召开日期：2025年10月28日 本次股东会采用的网络投票系统：中国证券登记结算有限责任公司股东 会网络投票系统 (二) 股东会召集人：董事会 (三) 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 (四) 现场会议召开的日期、时间和地点 字科技有限公司 (一) 股东会类型和届次 (五) 网络投票的系统、起止日期和投票时间。 网络投票系统：中国证券登记结算有限责任公司股东会网络投票系统 网络投票起止时间：自2025 年 10 月 27 日 至2025 年 10 月 28 日 投票时间为：自 2025 ...

Core Viewpoint - The article discusses the rising trend of Real World Assets (RWA) tokenization in the Greater Bay Area, highlighting its potential benefits and challenges for companies seeking to leverage this new financing model [4][5]. Group 1: RWA Tokenization Overview - RWA refers to the tokenization of real-world assets into tradable digital asset certificates using blockchain technology, with over 13 institutions exploring this model in the past two years [4][7]. - Companies are increasingly interested in RWA not just for financing but also for brand exposure and potential stock price enhancement [4][13]. Group 2: Recent Developments and Case Studies - Since 2024, notable companies like Langxin Group and Huaxia Fund have successfully issued RWA projects, with underlying assets including funds, bonds, and real estate [7][8]. - The total market value of global on-chain RWA assets surpassed $25 billion by July 2025, with projections suggesting the market could exceed $10 trillion by 2030 [9]. Group 3: Challenges and Risks - The costs associated with issuing RWA projects in Hong Kong can be high, often exceeding HKD 2.5 million, which may deter some companies from pursuing this route [11][12]. - Not all assets are suitable for RWA; successful tokenization requires stable cash flows, clear legal rights, and verifiable off-chain data [18][19]. Group 4: Regulatory Environment - The regulatory landscape for RWA is still evolving, with a need for clear classification and compliance pathways based on asset characteristics [19][20]. - There are concerns about systemic risks if transparency and custodial measures are not adequately enforced [20][21]. Group 5: Future Prospects - RWA could provide a new avenue for Chinese companies to return to the Hong Kong market, offering a more flexible and faster alternative to traditional secondary listings [24][25]. - The development of RWA is expected to align with economic trends, with potential breakthroughs in cross-border financial products and limited trials for equity assets [25].

Group 1 - Baiyun Airport announces joint investment with China Duty Free Group to establish a duty-free company with a registered capital of 45 million yuan, where China Duty Free Group holds 51% [3] - Dongxing Medical plans to acquire 90% stake in Wuhan Yijiaobao, a high-tech company focused on orthopedic and biomedical materials [4] - Fosun Pharma's subsidiary plans to transfer 100% stake in Shanghai Clone to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [5] Group 2 - Hengxing Technology's subsidiary is awaiting approval for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [6] - New Sai Co. announces resignation of its general manager Chen Jianjiang due to work adjustments [7] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [8] Group 3 - Zhejiang University Network plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [9] - Huazhong Precision terminates the issuance of A-shares to specific targets, affecting a control acquisition [10] - Jiaze New Energy states that its green chemical business is not yet commercially viable, with no significant impact on revenue or profit in the short term [11] Group 4 - Hailan Home plans to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [12] - Hongfuhang intends to invest up to 1.128 billion yuan in a joint venture to build a photovoltaic energy storage project in Congo [13] - Zhongchuang Zhiling plans to invest 5 billion yuan in a new energy vehicle parts industrial base and R&D center [14] Group 5 - Haitai Development's subsidiary signs a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [15] - Dongjie Intelligent's overseas subsidiary secures a procurement order worth approximately 180 million yuan, representing 22.3% of its audited revenue for 2024 [17] - Zhiguang Electric's subsidiary signs a procurement contract worth 164 million yuan for energy storage systems [18] Group 6 - ST Songfa's subsidiary signs a shipbuilding contract for four VLCCs, with a contract value between 400 million to 600 million USD [19] - Huaguang Huaneng signs a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [20] - Yousheng Co. receives a project notification from a German automaker, with total sales expected to reach approximately 2.3 billion yuan [24] Group 7 - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [25] - Compton plans to reduce holdings of repurchased shares by up to 1% [26] - Aored plans to reduce holdings of repurchased shares by up to 1.29% [27] Group 8 - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a new materials project [34] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [33] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production facility upgrades and working capital [34]

Major Events - Baiyun Airport announced a joint investment with China Duty Free Group to establish a duty-free company at Guangzhou Baiyun Airport with a registered capital of 45 million yuan, where China Duty Free will contribute 22.95 million yuan for a 51% stake [4] - Dongxing Medical plans to acquire 90% of Wuhan Yijiaobao's equity for cash, which is expected to constitute a major asset restructuring [5] - Fosun Pharma's subsidiary is planning to transfer 100% of Shanghai Clon to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [7] - Hengxing Technology's subsidiary is undergoing a review for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [8] - New Sai Co.'s general manager Chen Jianjiang resigned due to work adjustments [9] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [10] - Zhejiang University Net announced plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [11] - Huazhong Precision terminated its plan to issue A-shares to specific investors, which also halts the acquisition of control by a third party [12] - Jiazhe New Energy stated that its green chemical business is not yet commercially viable [13] Significant Contracts - Haitai Development's subsidiary signed a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [18] - Dongjie Intelligent's overseas subsidiary received a procurement order worth approximately 180 million yuan, accounting for 22.3% of the company's audited revenue for 2024 [19][20] - Zhiguang Electric's subsidiary signed a procurement contract worth 164 million yuan for energy storage systems [21] - ST Songfa's subsidiary signed contracts for building four oil tankers, with a total value between 400 million to 600 million USD [22] - Huaguang Huaneng signed a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [23] - Keda Intelligent plans to issue H-shares and list on the Hong Kong Stock Exchange, with details still under discussion [24] Shareholding Changes - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [28] - Compton plans to reduce up to 1% of its repurchased shares [29] - Aorede plans to reduce up to 1.29% of its shares from the repurchased stock [30] - Yidian Tianxia's controlling shareholder plans to reduce up to 3% of its shares [31] - Huace Film's shareholders plan to transfer 3.6% of the company's shares through an inquiry transfer [32] Buybacks and Financing - Qibin Group obtained a special financing support of up to 90 million yuan for share repurchase [33] - CanSino plans to cancel 406,100 repurchased shares and reduce registered capital accordingly [35] Fundraising Initiatives - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a high-performance paper-based new materials project [36] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [37] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production line upgrades and working capital [38]